1. Home
  2. PFSA vs DRCT Comparison

PFSA vs DRCT Comparison

Compare PFSA & DRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PFSA

Profusa Inc.

N/A

Current Price

$0.89

Market Cap

1.7M

Sector

Health Care

ML Signal

N/A

Logo Direct Digital Holdings Inc.

DRCT

Direct Digital Holdings Inc.

N/A

Current Price

$2.68

Market Cap

1.9M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
PFSA
DRCT
Founded
2009
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.7M
1.9M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
PFSA
DRCT
Price
$0.89
$2.68
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$32.00
AVG Volume (30 Days)
169.4K
16.3K
Earning Date
04-15-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$100,000.00
$34,694,000.00
Revenue This Year
N/A
$5.42
Revenue Next Year
N/A
$9.50
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.05
$0.04
52 Week High
$4.22
$7.21

Technical Indicators

Market Signals
Indicator
PFSA
DRCT
Relative Strength Index (RSI) 41.57 47.98
Support Level $0.84 $2.40
Resistance Level $2.25 $2.71
Average True Range (ATR) 0.11 0.17
MACD -0.05 0.02
Stochastic Oscillator 30.82 55.00

Price Performance

Historical Comparison
PFSA
DRCT

About PFSA Profusa Inc.

Profusa Inc is a clinical-stage digital health and medical technology company. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. The Lumee Oxygen Platform has been designed for use in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds that do not heal properly; and reconstructive surgery.

About DRCT Direct Digital Holdings Inc.

Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.

Share on Social Networks: